Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Preface (Proceedings of the VII Immunonutrition Workshop “Eating for Preventing” [Carovigno, (Italy) May 1-3, 2014] – First Part-)
Volume: 14 Issue: 4
Export Options
About this article
Cite this article as:
Preface (Proceedings of the VII Immunonutrition Workshop “Eating for Preventing” [Carovigno, (Italy) May 1-3, 2014] – First Part-), Endocrine, Metabolic & Immune Disorders - Drug Targets 2014; 14 (4) . https://dx.doi.org/10.2174/187153031404141112095924
DOI https://dx.doi.org/10.2174/187153031404141112095924 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
25
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Endoplasmic Reticulum Stress Related Molecular Mechanisms in Nonalcoholic Fatty Liver Disease (NAFLD)
Current Drug Targets Detection of Liver Metastases with Contrast Enhanced Ultrasonography
Current Medical Imaging Genetic Variation in SLCO2B1 is Associated with Serum Levels of Testosterone and its Metabolites Prior to and Two Days after Testosterone Administration
Current Pharmacogenomics and Personalized Medicine Novel Phytochemical Constituents and their Potential to Manage Diabetes
Current Pharmaceutical Design Lipoproteins and Diabetic Microvascular Complications
Current Pharmaceutical Design Coronary Artery Disease in Patients with Chronic Kidney Disease: A Clinical Update
Current Cardiology Reviews Functional and Structural Alterations of Large Arteries: Methodological Issues
Current Pharmaceutical Design An Overview of Targeting Legumain for Inhibiting Cancers
Current Pharmaceutical Design Having a Promising Efficacy on Type II Diabetes, It’s Definitely a Green Tea Time
Current Medicinal Chemistry Effect of Conjugated Linoleic Acid as a Supplement or Enrichment in Foods on Blood Glucose and Waist Circumference in Humans: A Metaanalysis
Endocrine, Metabolic & Immune Disorders - Drug Targets Cytochrome P450 2C8 and Drug Metabolism
Current Topics in Medicinal Chemistry Erythropoietin in Heart Failure and Other Cardiovascular Diseases: Hematopoietic and Pleiotropic Effects
Current Drug Targets - Cardiovascular & Hematological Disorders Applications of Chemical Shift Imaging for AD
Current Medical Imaging Meet Our Editorial Board Member
Endocrine, Metabolic & Immune Disorders - Drug Targets Directing Hypoxic Tumor Microenvironment and HIF to Illuminate Cancer Immunotherapy's Existing Prospects and Challenges in Drug Targets
Current Drug Targets Heparan Sulphate as a Regulator of Leukocyte Recruitment in Inflammation
Current Protein & Peptide Science Medical Gains of Chondroitin Sulfate Upon Fucosylation
Current Medicinal Chemistry Diverse Functions and Mechanisms of Pericytes in Ischemic Stroke
Current Neuropharmacology Hypoxia-Inducible Factor 1 in Tumor Radioresistance
Current Signal Transduction Therapy Diabetic Retinopathy: Current and New Treatment Options
Current Diabetes Reviews